
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1080 | 1080 | 1057 | 1215 | 1775 | 1716 |
Fund Return | 7.96% | 7.96% | 5.65% | 6.71% | 12.16% | 5.55% |
Place in category | 181 | 181 | 390 | 145 | 219 | 133 |
% in Category | 22 | 22 | 59 | 24 | 36 | 36 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Schwab S&P 500 Index | 102.47B | -4.28 | 9.03 | 12.46 | ||
Schwab Total Stock Market Index | 25.12B | -4.86 | 8.10 | 11.69 | ||
Schwab 1000 Index | 16.52B | -4.60 | 8.51 | 11.97 | ||
Schwab Fundamental US Large Company | 8.98B | 0.14 | 8.70 | 11.31 | ||
Schwab Small Cap Index | 5.62B | -9.44 | 0.59 | 6.36 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 209.79B | 5.46 | 4.59 | 5.14 | ||
Vanguard Total Intl Stock Index Adm | 76.18B | 5.51 | 4.65 | 5.21 | ||
Fidelity International Index Inst | 56.32B | 7.95 | 6.78 | 5.63 | ||
Fidelity Series Global ex US Index | 52.22B | 6.14 | 5.03 | 5.09 | ||
Strategic Advisers International I | 45.83B | 7.61 | 6.38 | 6.21 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 1.68 | 420.3 | +2.62% | |
SAP | DE0007164600 | 1.67 | 224.800 | -2.26% | |
ASML Holding | NL0010273215 | 1.61 | 577.30 | -0.05% | |
Nestle | CH0038863350 | 1.46 | 84.98 | +0.81% | |
AstraZeneca | GB0009895292 | 1.35 | 10,008.0 | -0.10% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review